Namita Sood (University of Texas Health Science Center, Houston, TX, US) discusses challenges and advances in pulmonary arterial hypertension (PAH).
1. What is the definition of pulmonary arterial hypertension (PAH)? (0:10)
2. What are the major challenges in the diagnosis of PAH? (0:43)
3. How is PAH classified and what are the most important diagnostic criteria? (1:24)
4. What are the recommended disease-specific and supportive therapies for PAH? (2:12)
5. What have been the most important advances in the management of PAH in recent years? (2:56)
Speaker disclosure: Namita Sood has nothing to disclose in relation to this video interview.
Filmed at the CHEST Annual Meeting, San Antonio, TX, US, October 2018.
Share this Video
Related Videos In Pulmonary Hypertension
Luis Jara Palomares, ERS 2019 – Environmental Factors in Pulmonary Embolism and PAH
Luis Jara-Palomares, from Seville, Spain, joins us at ERS 2019 in Madrid, to discuss the main findings from his study into the significance of environmental factors in pulmonary embolism and pulmonary arterial hypertension. Questions 1. What are the major causes of pulmonary embolism and pulmonary arterial hypertension? (0:06) 2. What is known about the impact […]
Sandeep Sahay, ATS 2019 – New World Symposium Proceedings on Pulmonary Hypertension
Sandeep Sahay (Houston Methodist Lung Center, Houston Methodist Hospital, Houston, TX, USA) speaks from the 2019 ATS conference in Dallas, TX, USA about portopulmonary hypertension, how it differs from other types of hypertension and changes to the diagnostic criteria. He also addresses the changes this will have on patients and addressing unmet needs in hypertension. […]
James R Klinger, CHEST 2018 – Management of pulmonary arterial hypertension
James R Klinger (Rhode Island Hospital, and Warren Alpert Medical School, Brown University, Providence, RI, US) chats to us on the topic of his session entitled: Current Quandaries in Pulmonary Arterial Hypertension (PAH) Management. Questions 1. What are the major challenges in the management of pulmonary arterial hypertension (PAH)? (0:10) 2. What have been the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!